Addressing the relationship between sympathetic activity and inflammation.
Hausberg
Martin
M
Hillebrand
Uta
U
Kisters
Klaus
K
D000959:Antihypertensive Agents / Q000494:pharmacology; D001262:Atenolol / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000378:metabolism / Q000503:physiopathology; D007093:Imidazoles / Q000627:therapeutic use; D007249:Inflammation / Q000503:physiopathology*; D007333:Insulin Resistance / Q000502:physiology; D008875:Middle Aged; D050177:Overweight / Q000378:metabolism / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D000959:Antihypertensive Agents; D007093:Imidazoles; D014409:Tumor Necrosis Factor-alpha; D001262:Atenolol; D002097:C-Reactive Protein; C043482:moxonidine